Overactive Bladder in Diabetes Mellitus

被引:3
作者
Narayanamurthy, Vaishnavi [1 ]
Slopnick, Emily A. [1 ,2 ]
Sheyn, David D. [1 ,2 ]
Bukavina, Laura [1 ,2 ]
Mishra, Kirtishri [1 ,2 ]
Hijaz, Adonis K. [1 ,2 ]
机构
[1] Case Western Reserve Univ, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Inst Urol, Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA
关键词
Overactive bladder; Diabetes mellitus; Incontinence; Urinary tract infection; INTRAVESICAL ONABOTULINUMTOXINA INJECTION; TIBIAL NERVE-STIMULATION; LIFE-STYLE INTERVENTION; QUALITY-OF-LIFE; TOXIN TYPE-A; BOTULINUM-TOXIN; SACRAL NEUROMODULATION; URINARY-INCONTINENCE; PREVALENCE; SYMPTOMS;
D O I
10.1007/s11884-019-00532-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewTo explore the current literature regarding the epidemiology, pathophysiology, diagnosis, and management of overactive bladder in diabetic patients.Recent FindingsOveractive bladder is a syndrome complex of urinary urgency, often accompanied by frequency and nocturia. Several studies have established the relationship between diabetes mellitus and bladder dysfunction. However, there is limited literature available to evaluate the prevalence of overactive bladder in this population and to guide clinical practice. The introduction of medications such as mirabegron and minimally invasive techniques such as intravesicular onabotulinumtoxinA injections has resulted in a shift in the treatment model for overactive bladder. New technologies for treatment such as radiofrequency therapy are also under active development. Ongoing research seeks to further understand the mechanisms involved in the pathogenesis of overactive bladder and identify biomarkers.SummaryWith the increasing prevalence of diabetes mellitus, it is expected that patients with overactive bladder symptoms will be seen more frequently. The American Urological Association (AUA) and Society of Urodynamics and the Female Pelvic Medicine & Urogenital Reconstruction (SUFU) recently updated the guidelines for the diagnosis for overactive bladder in 2019. However, there are important considerations in diabetic patients that may alter clinical evaluation and management. We tried to shed some light on these diagnostic considerations and the management options available to diabetic patients.
引用
收藏
页码:324 / 330
页数:7
相关论文
共 54 条
[1]   Diabetes and the occurrence of infection in primary care: a matched cohort study [J].
Abu-Ashour, Waseem ;
Twells, Laurie K. ;
Valcour, James E. ;
Gamble, John-Michael .
BMC INFECTIOUS DISEASES, 2018, 18
[2]   Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up [J].
Angioli, Roberto ;
Montera, Roberto ;
Plotti, Francesco ;
Aloisi, Alessia ;
Montone, Eva ;
Zullo, Marzio Angelo .
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 (05) :789-794
[3]   An external compress-release protocol induces dynamic elasticity in the porcine bladder: A novel technique for the treatment of overactive bladder? [J].
Balthazar, Andrea ;
Cullingsworth, Zachary E. ;
Nandanan, Naveen ;
Anele, Uzoma ;
Swavely, Natalie R. ;
Speich, John E. ;
Klausner, Adam P. .
NEUROUROLOGY AND URODYNAMICS, 2019, 38 (05) :1222-1228
[4]   Urinary bladder, cystitis and nerve/urothelial interactions [J].
Birder, Lori A. .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2014, 182 :89-94
[5]   Lifestyle intervention is associated with lower prevalence of urinary incontinence - The Diabetes Prevention Program [J].
Brown, JS ;
Wing, R ;
Barrett-Connor, E ;
Nyberg, LM ;
Kusek, JW ;
Orchard, TJ ;
Ma, Y ;
Vittinghoff, E ;
Kanaya, AM .
DIABETES CARE, 2006, 29 (02) :385-390
[6]   Rationale for the Use of Anticholinergic Agents in Overactive Bladder With Regard to Central Nervous System and Cardiovascular System Side Effects [J].
Cetinel, Bulent ;
Onal, Bulent .
KOREAN JOURNAL OF UROLOGY, 2013, 54 (12) :806-815
[7]   Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study [J].
Coupland, Carol A. C. ;
Hill, Trevor ;
Dening, Tom ;
Morriss, Richard ;
Moore, Michael ;
Hippisley-Cox, Julia .
JAMA INTERNAL MEDICINE, 2019, 179 (08) :1084-1093
[8]   National Community Prevalence of Overactive Bladder in the United States Stratified by Sex and Age [J].
Coyne, Karin S. ;
Sexton, Chris C. ;
Vats, Vasudha ;
Thompson, Christine ;
Kopp, Zoe S. ;
Milsom, Ian .
UROLOGY, 2011, 77 (05) :1081-1087
[9]   Botulinum Toxin-A Injections for Idiopathic Overactive Bladder: A Systematic Review and Meta-Analysis [J].
Cui, Yu ;
Wang, Long ;
Liu, Longfei ;
Zeng, Feng ;
Niu, Jiping ;
Qi, Lin ;
Chen, Hequn .
UROLOGIA INTERNATIONALIS, 2013, 91 (04) :429-438
[10]   Diabetic uropathy [J].
Daneshgari, F ;
Moore, C .
SEMINARS IN NEPHROLOGY, 2006, 26 (02) :182-185